Phase II Double-Blind, Placebo Controlled, Randomized Study Of Celecoxib, A Selective COX-2 Inhibitor, In Oral Premalignant Lesions
Phase of Trial: Phase II
Latest Information Update: 15 Jan 2013
At a glance
- Drugs Celecoxib (Primary)
- Indications Head and neck cancer
- Focus Therapeutic Use
- 15 Jan 2013 Last checked against ClinicalTrials.gov record.
- 17 Dec 2009 Actual end date (Jan 2006) added as reported by ClinicalTrials.gov.
- 28 Jul 2008 Status changed from in progress to completed